Recommendations to Reduce the Risk of Transfusion-Transmitted Malaria: Draft Guidance for Industry
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
January 15, 2025
January 17, 2025
1eea49f3-76b0-45d6-81c4-4a91e8a41311
Related Documents
Potency Assurance for Cellular and Gene Therapy Products
Guidance DocumentDecember 27, 2023Center for Biologics Evaluation and Research
Recommendations for Determining Eligibility of Donors of Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT/Ps): Draft Guidance for Industry
Guidance DocumentJanuary 6, 2025Center for Biologics Evaluation and Research
Manufacturing Changes and Comparability for Human Cellular and Gene Therapy Products
Guidance DocumentJuly 13, 2023Center for Biologics Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox